E
MindBio Therapeutics Corp. MBIO
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses 163.92% -69.91%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 186.99% 22.45%
Operating Income -186.99% 89.67%
Income Before Tax -725.08% 82.62%
Income Tax Expenses -- --
Earnings from Continuing Operations -725.08% 82.62%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings 800.00% --
Net Income -705.21% 82.39%
EBIT -186.99% 89.67%
EBITDA -- --
EPS Basic -800.00% 84.62%
Normalized Basic EPS -1,000.00% 87.50%
EPS Diluted -800.00% 84.62%
Normalized Diluted EPS -1,000.00% 87.50%
Average Basic Shares Outstanding 0.88% -2.21%
Average Diluted Shares Outstanding 0.88% -2.21%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings